| Jack A Mandel Jr, CRNA | |
|
4901 Grande Dr, Pensacola, FL 32504-5935 | |
| (850) 477-7042 | |
| (850) 474-9060 |
| Full Name | Jack A Mandel Jr |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 4901 Grande Dr, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033449178 | NPI | - | NPPES |
| 116242 | Medicaid | AL | |
| 592-10135 | Other | AL | BLUE CROSS BLUE SHIELD |
| 001818300 | Medicaid | FL | |
| G0071 | Other | FL | BLUE CROSS BLUE SHIELD |
| P00810162 | Other | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP9299697 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ams Anesthetist Services Llc | 8325298458 | 144 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
| Entity Name | Ams Anesthetist Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770834426 PECOS PAC ID: 8325298458 Enrollment ID: O20121025000224 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
| Entity Name | Ams Sacred Heart Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457614851 PECOS PAC ID: 5395995427 Enrollment ID: O20121107000144 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140128001202 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
| Entity Name | Ams National Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316330830 PECOS PAC ID: 3870813025 Enrollment ID: O20150529000613 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jack A Mandel Jr, CRNA 4901 Grande Dr, Pensacola, FL 32504-5935 Ph: (850) 477-7042 | Jack A Mandel Jr, CRNA 4901 Grande Dr, Pensacola, FL 32504-5935 Ph: (850) 477-7042 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
› Verified 6 days ago
Katherine Kuehn, ARNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8383 N Davis Hwy, Pensacola, FL 32514 Phone: 850-494-6098 Fax: 850-494-5150 | |
Kaitlyn Brown, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 8383 N Davis Hwy, Pensacola, FL 32514 Phone: 850-494-3212 | |
Brian Grady Watson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8383 N Davis Hwy, Pensacola, FL 32514 Phone: 228-257-5070 Fax: 850-494-5150 | |
Leslie Street, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4901 Grande Dr, Pensacola, FL 32504 Phone: 850-477-7042 Fax: 850-474-9060 | |
Katherine B Bryan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, Medical Center Clinic, Pensacola, FL 32514 Phone: 850-474-8319 Fax: 850-969-2958 | |
Mrs. Casey Hitt Anderson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4901 Grande Dr, Pensacola, FL 32504 Phone: 850-477-7042 Fax: 850-474-9060 | |
Darrah L Friedman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4901 Grande Dr, Pensacola, FL 32504 Phone: 850-477-7042 Fax: 850-474-9060 |